Covered recipient · General Payments record
RICHARD S MAYROSE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2021
$1,515.92
- Reported across 104 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $233.85 | 13 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $108.19 | 6 |
| Amgen Inc. | $45.38 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $35.69 | 2 |
| Novo Nordisk AS | $18.75 | 1 |
| Biohaven Pharmaceuticals, Inc. | $13.08 | 1 |
| Merck Sharp & Dohme Corporation | $12.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $17.36 | 02/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795560772 | CMS |
| AbbVie Inc. | $14.34 | 02/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795560777 | CMS |
| AbbVie Inc. | $19.56 | 03/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795560783 | CMS |
| AbbVie Inc. | $20.35 | 04/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795560789 | CMS |
| AbbVie Inc. | $21.52 | 04/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795560793 | CMS |
| AbbVie Inc. | $15.06 | 05/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795560799 | CMS |
| Amgen Inc. | $26.67 | 02/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825723181 | CMS |
| Amgen Inc. | $18.71 | 03/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825723185 | CMS |
| Biohaven Pharmaceuticals, Inc. | $13.08 | 01/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 852561801 | CMS |
| Merck Sharp & Dohme Corporation | $12.76 | 04/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848541689 | CMS |
| Novo Nordisk Inc | $18.75 | 02/25/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836094953 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.33 | 03/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | 820074671 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.36 | 04/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 820074677 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.